Showing results (231-240 of 369) with videos related to
Sort By:
Pageof 37
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2024
Androgen Deprivation Therapy Drives a Distinct Immune Phenotype in Localized Prostate CancerMatthew C Dallos, Aleksandar Z Obradovic, Patrick McCann, et al.JAMA Oncology|June 5, 2016
Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate CancerHoward I Scher, David Lu, Nicole A Schreiber, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancerDana E Rathkopf, Michael J Morris, Josef J Fox, et al.European Urology|September 19, 2022
Analysis of BRCA2 Copy Number Loss and Genomic Instability in Circulating Tumor Cells from Patients with Metastatic Castration-resistant Prostate CancerEthan S Barnett, Nikolaus Schultz, Konrad H Stopsack, et al.Cancer Research|August 21, 2020
Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate CancerJoseph D Schonhoft, Jimmy L Zhao, Adam Jendrisak, et al.Cancer Chemotherapy and Pharmacology|November 30, 2011
A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumorsGopa Iyer, Michael J Morris, Dana Rathkopf, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 19, 2010
Pharmacokinetic assessment of the uptake of 16beta-18F-fluoro-5alpha-dihydrotestosterone (FDHT) in prostate tumors as measured by PETBradley J Beattie, Peter M Smith-Jones, Yuliya S Jhanwar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2007
Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guidelineD Andrew Loblaw, Katherine S Virgo, Robert Nam, et al.Clinical Genitourinary Cancer|February 14, 2009
Department of Defense prostate cancer clinical trials consortium: a new instrument for prostate cancer clinical researchMichael J Morris, Ethan M Basch, George Wilding, et al.Cancer Research|August 19, 2017
Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate CancerHoward I Scher, Ryon P Graf, Nicole A Schreiber, et al.Pageof 37